Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance (Q33716008)

28 July 2017

title

Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance (English)

1 reference

28 July 2017

1 reference

5

Patricia K Donahoe

1 reference

28 July 2017

3

Esther Oliva

1 reference

28 July 2017

Elizabeth J Renaud

1

1 reference

28 July 2017

David T MacLaughlin

series ordinal

2

1 reference

28 July 2017

Bo R Rueda

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

23 December 2004

1 reference

28 July 2017

number of pages

6

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

28 July 2017

volume

102

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

111-116

1 reference

Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Sex determination and differentiation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

21 June 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Anti-Müllerian hormone and its receptors

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Persistence of Müllerian derivatives in males

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

The retinoblastoma gene family in differentiation and development.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

P16/MTS1 and pRB expression in endometrial carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

p53-independent role of MDM2 in TGF-beta1 resistance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Developmental expression of a candidate müllerian inhibiting substance type II receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Inhibitors of mammalian G1 cyclin-dependent kinases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Recent progress in ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=544070

Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0407772101

Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0407772101

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0407772101

New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity

21 January 2018

1 reference

12 December 2020

Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo

1 reference

12 December 2020

Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary

1 reference

12 December 2020

A new look at the mechanisms controlling sex differentiation in mammals

1 reference

12 December 2020

Müllerian-inhibiting substance function during mammalian sexual development

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0407772101

1 reference

28 July 2017

0 references

1 reference

28 July 2017

1 reference